Ascensia Diabetes Care en LinkedIn: Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for…
![Senseonics Holdings Is A Winner With The Ascensia Deal In Glucose Monitoring (NYSE:SENS) | Seeking Alpha Senseonics Holdings Is A Winner With The Ascensia Deal In Glucose Monitoring (NYSE:SENS) | Seeking Alpha](https://static.seekingalpha.com/uploads/2020/11/13/51411522-16052789054225736_origin.png)
Senseonics Holdings Is A Winner With The Ascensia Deal In Glucose Monitoring (NYSE:SENS) | Seeking Alpha
![Ascensia Diabetes Care on Twitter: "Following this week's Eversense E3 #CGM launch, learn more about the components of @senseonics innovative CGM #technology below in three simple steps. https://t.co/bGKJIHBDDR" / Twitter Ascensia Diabetes Care on Twitter: "Following this week's Eversense E3 #CGM launch, learn more about the components of @senseonics innovative CGM #technology below in three simple steps. https://t.co/bGKJIHBDDR" / Twitter](https://pbs.twimg.com/tweet_video_thumb/FPvkgZlWYAowmlQ.jpg)
Ascensia Diabetes Care on Twitter: "Following this week's Eversense E3 #CGM launch, learn more about the components of @senseonics innovative CGM #technology below in three simple steps. https://t.co/bGKJIHBDDR" / Twitter
![Ascensia Diabetes Care on Twitter: "#ICYMI the FDA recently approved the Eversense E3 #CGM system for use for up to six months, offering people with #diabetes more choices for their self-management. Learn Ascensia Diabetes Care on Twitter: "#ICYMI the FDA recently approved the Eversense E3 #CGM system for use for up to six months, offering people with #diabetes more choices for their self-management. Learn](https://pbs.twimg.com/media/FMNqwu_XMAMdox3.jpg)
Ascensia Diabetes Care on Twitter: "#ICYMI the FDA recently approved the Eversense E3 #CGM system for use for up to six months, offering people with #diabetes more choices for their self-management. Learn
![ASCENSIA DIABETES CARE LAUNCHES THE 6 MONTH EVERSENSE® E3 CONTINUOUS GLUCOSE MONITORING SYSTEM IN THE U.S. WITH THE NEW EVERSENSE PASS SAVINGS PROGRAM ASCENSIA DIABETES CARE LAUNCHES THE 6 MONTH EVERSENSE® E3 CONTINUOUS GLUCOSE MONITORING SYSTEM IN THE U.S. WITH THE NEW EVERSENSE PASS SAVINGS PROGRAM](https://mma.prnewswire.com/media/1778839/Eversense_E3.jpg)